Additionally, loss of TET2 in GC B-cells was recently shown to mirror many of the mechanistic and functional effects observed in CREBBP-mutant DLBCL, including enhancer inactivation and inhibition of GC exit and plasma cell differentiation111 (Fig. 5). Here, CREBBP is linked to diffuse large B-cell lymphoma.